Multicompartment models of cancer chemotherapy incorporating resistant cell populations
- PMID: 3612499
- DOI: 10.1007/BF01062341
Multicompartment models of cancer chemotherapy incorporating resistant cell populations
Abstract
The pharmacokinetics of antineoplastic drugs based on compartmental models are combined with deterministic exponential growth models of tumors containing drug-resistant and sensitive cells. Model predictions for single-drug therapy are compared with in vivo data obtained by other investigators for L1210 t-cell leukemia in mice treated with BCNU and Ara-C and for in vitro treatment of L1210 with Ara-C. The model and data compare favorably in terms of rate of tumor growth and duration of drug action for both constant infusion and bolus delivery of the drugs.
Similar articles
-
Comparison of the activity of arabinosyl-5-azacytosine, arabinosyl cytosine, and 5-azacytidine against intracerebrally implanted L1210 leukemia.Invest New Drugs. 1985;3(4):331-4. doi: 10.1007/BF00170754. Invest New Drugs. 1985. PMID: 2417984
-
Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.Cancer Res. 1987 May 1;47(9):2323-7. Cancer Res. 1987. PMID: 3567926
-
Electronic volume analysis of L1210 chemotherapy.Cancer Res. 1976 Dec;36(12):4434-8. Cancer Res. 1976. PMID: 1000492
-
[The mechanism of synergistic interaction between etoposide and cytarabine].Yakugaku Zasshi. 2002 Jul;122(7):471-80. doi: 10.1248/yakushi.122.471. Yakugaku Zasshi. 2002. PMID: 12136643 Review. Japanese.
-
Murine and human leukemias.Bibl Haematol. 1975;(40):665-77. doi: 10.1159/000397589. Bibl Haematol. 1975. PMID: 1100047 Review.
Cited by
-
Mathematical models for multidrug resistance and its reversal.Cytotechnology. 1993;12(1-3):315-24. doi: 10.1007/BF00744670. Cytotechnology. 1993. PMID: 7765330 Review.